Late-phase 3 EAD. A unique mechanism contributing to initiation of atrial fibrillation
about
Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleevesAZD1305 exerts atrial predominant electrophysiological actions and is effective in suppressing atrial fibrillation and preventing its reinduction in the dogMechanisms of cardiac arrhythmiasSynchronization of chaotic early afterdepolarizations in the genesis of cardiac arrhythmias.Mechanisms of stretch-induced atrial fibrillation in the presence and the absence of adrenocholinergic stimulation: interplay between rotors and focal discharges.Short QT syndrome: from bench to bedside.Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.Genesis of phase 3 early afterdepolarizations and triggered activity in acquired long-QT syndrome.Overview of Basic Mechanisms of Cardiac ArrhythmiaAntiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparationsAntiarrhythmic effects of losartan and enalapril in canine pulmonary vein sleeve preparations.Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillationNovel pharmacological targets for the rhythm control management of atrial fibrillation.Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.Electrophysiological characteristics of canine superior vena cava sleeve preparations: effect of ranolazine.Triggered firing and atrial fibrillation in transgenic mice with selective atrial fibrosis induced by overexpression of TGF-β1.Reduction in Kv Current Enhances the Temporal Dispersion of the Action Potential in Diabetic Myocytes: Insights From a Novel Repolarization Algorithm.Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.Early afterdepolarizations in cardiac myocytes: beyond reduced repolarization reserveFever accentuates transmural dispersion of repolarization and facilitates development of early afterdepolarizations and torsade de pointes under long-QT Conditions.Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation.Atrial-selective sodium channel blockers: do they exist?Potent antiarrhythmic effects of chronic amiodarone in canine pulmonary vein sleeve preparationsMutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization.Dynamics of the late Na(+) current during cardiac action potential and its contribution to afterdepolarizations.Atrial-selective sodium channel block for the treatment of atrial fibrillation.Altered Excitation-Contraction Coupling in Human Chronic Atrial Fibrillation.New pharmacological strategies for the treatment of atrial fibrillationNew developments in atrial antiarrhythmic drug therapy.The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications.Supplemental studies for cardiovascular risk assessment in safety pharmacology: a critical overview.Do t-tubules play a role in arrhythmogenesis in cardiac ventricular myocytes?New antiarrhythmic targets to control intracellular calcium handling.Pulmonary Vein Sleeves as a Pharmacologic Model for the Study of Atrial Fibrillation.Ca²⁺-induced delayed afterdepolarizations are triggered by dyadic subspace Ca2²⁺ affirming that increasing SERCA reduces aftercontractions.Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation.How Do Atrial-Selective Drugs Differ From Antiarrhythmic Drugs Currently Used in the Treatment of Atrial Fibrillation?Mathematical simulations of ligand-gated and cell-type specific effects on the action potential of human atrium.How Do Atrial-Selective Drugs Differ From Antiarrhythmic Drugs Currently Used in the Treatment of Atrial Fibrillation?The action potential of the Purkinje fiber: an in vitro model for evaluation of the proarrhythmic potential of cardiac and noncardiac drugs.
P2860
Q24601144-2B3CCC64-69F9-4FAE-B1C5-E590CEF35FA3Q24607775-A6558608-525C-4D7C-BD02-983EE09A4E9BQ26752476-3F3A986C-A699-4215-AF0C-674A5107BF26Q30486315-DAE77B37-B05D-4406-8837-9E04ECEB88BEQ30494264-302DF2D5-8079-450E-BE73-66EA71F74DE8Q34102891-EC9D5CAC-145E-4F9A-AD73-9CF38FABDCA4Q34181734-23B75BCF-1F17-4168-8E2D-6853BCDBE48CQ34607621-FF902708-89E0-4236-9F82-AFBB12D9022DQ34632042-AA61F03D-7F33-40B9-9D99-A7200137AD42Q34682939-87DC2564-26B8-4D73-BC32-485D0EEA33AEQ34700436-C38C4E86-C55F-4E6F-83DB-B19EBA1B1D49Q34765700-95B661FB-FDAA-452A-8668-478747C54672Q35489060-DABAB690-5242-494E-8B6D-DA59B2FDE8B7Q35785780-39FBCC54-818D-45EC-B786-942FA9464DF5Q35897540-E29ADE5C-9C43-4896-A800-ABE59DE3794AQ36671389-EC849C6C-0664-4F72-AD5B-01BD502F6EA5Q36714022-485D9AB9-28B7-479E-A191-B56E33D40BC1Q36839147-06D941BC-1E40-4172-B161-5BCDDBC8A836Q36943422-D2CFAEEA-C8C3-4BE0-987E-16E15C9713C1Q37011111-165AA74B-D951-454B-A6ED-B861A49FD120Q37093085-399B61B3-0FF6-4EBA-BB9A-F3B350D1EE28Q37231700-39D163B1-45F4-4289-B707-225C3B272B8FQ37315220-2A3C53A2-8FB3-492C-888D-2837DA29969CQ37315854-D50F1C13-2865-4DA4-BE38-F971185601CFQ37377307-8CA92237-05BD-45B1-9D4C-3B64F3688B29Q37494653-AA0395AA-5382-493F-B908-0719D9032BF6Q37496226-8FF67084-948E-4F55-B0A5-0528B75D857EQ37554693-22B2E717-1D56-488D-BA30-AC0EC998C130Q37697498-181C1607-84C1-49D3-AEBA-347CCAF8568DQ37799958-524C8234-9409-41C7-B70E-166A11D5FF26Q37909132-AF1B5885-5F22-49C7-9ABB-61FBAE5B14BFQ38104947-53D67C5B-EC4F-4678-9E70-340EA9E698D3Q38204723-17770779-56A2-4B5E-BFE5-12A94230BF73Q38226807-9982535F-000E-4EEB-8B62-B0071980C368Q38677208-9AA1ACE5-AFEC-4E68-A5E6-87F11131D3BAQ38703115-B5BF3AA3-FD53-482C-A82E-E0830A2C1A06Q38790685-FB2C1840-9A35-465D-9B61-F39C226DA993Q39568164-60736B56-CB75-4603-8F94-2D5AEDF4D76BQ42385429-1EF8E03A-6976-46A3-A986-5D45B0C9385FQ42721783-05007D61-802E-4BDF-9EC5-F0378ECD32B6
P2860
Late-phase 3 EAD. A unique mechanism contributing to initiation of atrial fibrillation
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Late-phase 3 EAD. A unique mechanism contributing to initiation of atrial fibrillation
@ast
Late-phase 3 EAD. A unique mechanism contributing to initiation of atrial fibrillation
@en
type
label
Late-phase 3 EAD. A unique mechanism contributing to initiation of atrial fibrillation
@ast
Late-phase 3 EAD. A unique mechanism contributing to initiation of atrial fibrillation
@en
prefLabel
Late-phase 3 EAD. A unique mechanism contributing to initiation of atrial fibrillation
@ast
Late-phase 3 EAD. A unique mechanism contributing to initiation of atrial fibrillation
@en
P2860
P1476
Late-phase 3 EAD. A unique mechanism contributing to initiation of atrial fibrillation
@en
P2093
Alexander Burashnikov
P2860
P304
P356
10.1111/J.1540-8159.2006.00336.X
P577
2006-03-01T00:00:00Z